Early and late mortality after malaria in young children in Papua, Indonesia.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
30 Oct 2019
Historique:
received: 28 04 2018
accepted: 23 09 2019
entrez: 1 11 2019
pubmed: 2 11 2019
medline: 3 1 2020
Statut: epublish

Résumé

In southern Papua, Indonesia, malaria is highly prevalent in young children and is a significant cause of morbidity and early mortality. The association between malaria and delayed mortality is unknown. Routinely-collected hospital surveillance data from southern Papua, Indonesia, were used to assess the risk of recurrent malaria and mortality within 12 months of an initial presentation with malaria in all children younger than 5 years old attending the local hospital. Analysis was primarily by Kaplan Meier and Cox regression methods. In total 15,716 children presenting with malaria between April 2004 and December 2013 were included in the analysis; 6184 (39.3%) with Plasmodium falciparum, 7499 (47.7%) with P. vivax, 203 (1.3%) with P. malariae, 3 with P. ovale and 1827 (11.6%) with mixed infections. Within 1 year, 48.4% (7620/15,716) of children represented a total of 16,957 times with malaria (range 1 to 11 episodes), with the incidence of malaria being greater in patients initially presenting with P. vivax infection (1334 [95%CI 1307-1361] per 1000 patient years) compared to those with P. falciparum infection (920 [896-944]). In total 266 (1.7%) children died within 1 year of their initial presentation, 129 (48.5%) within 30 days and 137 (51.5%) between 31 and 365 days. There was no significant difference in the mortality risk in patients infected with P. vivax versus P. falciparum either before 30 days (Hazard Ratio (HR) 1.02 [0.69,1.49]) or between 31 and 365 days (HR = 1.30 [0.90,1.88]). Children who died had a greater incidence of malaria, 2280 [95%CI 1946-2671] per 1000 patient years preceding their death, compared to 1141 [95%CI 1124-1158] per 1000 patient years in those surviving. Children under-5 years old with P. vivax malaria, are at significant risk of multiple representations with malaria and of dying within 1 year of their initial presentation. Preventing recurrent malaria must be a public health priority in this vulnerable population.

Sections du résumé

BACKGROUND BACKGROUND
In southern Papua, Indonesia, malaria is highly prevalent in young children and is a significant cause of morbidity and early mortality. The association between malaria and delayed mortality is unknown.
METHODS METHODS
Routinely-collected hospital surveillance data from southern Papua, Indonesia, were used to assess the risk of recurrent malaria and mortality within 12 months of an initial presentation with malaria in all children younger than 5 years old attending the local hospital. Analysis was primarily by Kaplan Meier and Cox regression methods.
RESULTS RESULTS
In total 15,716 children presenting with malaria between April 2004 and December 2013 were included in the analysis; 6184 (39.3%) with Plasmodium falciparum, 7499 (47.7%) with P. vivax, 203 (1.3%) with P. malariae, 3 with P. ovale and 1827 (11.6%) with mixed infections. Within 1 year, 48.4% (7620/15,716) of children represented a total of 16,957 times with malaria (range 1 to 11 episodes), with the incidence of malaria being greater in patients initially presenting with P. vivax infection (1334 [95%CI 1307-1361] per 1000 patient years) compared to those with P. falciparum infection (920 [896-944]). In total 266 (1.7%) children died within 1 year of their initial presentation, 129 (48.5%) within 30 days and 137 (51.5%) between 31 and 365 days. There was no significant difference in the mortality risk in patients infected with P. vivax versus P. falciparum either before 30 days (Hazard Ratio (HR) 1.02 [0.69,1.49]) or between 31 and 365 days (HR = 1.30 [0.90,1.88]). Children who died had a greater incidence of malaria, 2280 [95%CI 1946-2671] per 1000 patient years preceding their death, compared to 1141 [95%CI 1124-1158] per 1000 patient years in those surviving.
CONCLUSIONS CONCLUSIONS
Children under-5 years old with P. vivax malaria, are at significant risk of multiple representations with malaria and of dying within 1 year of their initial presentation. Preventing recurrent malaria must be a public health priority in this vulnerable population.

Identifiants

pubmed: 31666012
doi: 10.1186/s12879-019-4497-y
pii: 10.1186/s12879-019-4497-y
pmc: PMC6820991
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

922

Subventions

Organisme : National Health and Medical Research Council
ID : 1135820
Organisme : Wellcome Trust
ID : 200909/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200909
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 099875
Pays : United Kingdom
Organisme : National Health and Medical Research Council
ID : 1037304
Organisme : National Health and Medical Research Council
ID : 1104975

Références

PLoS Med. 2008 Jun 17;5(6):e128
pubmed: 18563962
Am J Trop Med Hyg. 2018 Feb;98(2):543-550
pubmed: 29280424
PLoS Med. 2017 Aug 29;14(8):e1002379
pubmed: 28850568
Lancet. 2007 Mar 3;369(9563):757-765
pubmed: 17336652
Am J Trop Med Hyg. 2003 Apr;68(4):416-20
pubmed: 12875290
Malar J. 2011 Oct 11;10:297
pubmed: 21989376
PLoS Med. 2013 Dec;10(12):e1001575; discussion e1001575
pubmed: 24358031
Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):55-63
pubmed: 15331819
Malar J. 2013 May 31;12:176
pubmed: 23721247
Am J Clin Nutr. 2004 Dec;80(6):1604-10
pubmed: 15585775
Clin Infect Dis. 2008 May 1;46(9):1374-81
pubmed: 18419439
Malar J. 2012 Apr 27;11:135
pubmed: 22540175
BMC Med. 2014 Nov 18;12:217
pubmed: 25406857
Clin Infect Dis. 2009 Jun 15;48(12):1704-12
pubmed: 19438395
Adv Parasitol. 2012;80:151-201
pubmed: 23199488
PLoS Pathog. 2015 Jan 08;11(1):e1004558
pubmed: 25569250
Trop Med Int Health. 2014 Sep;19 Suppl 1:7-131
pubmed: 25214480
Trans R Soc Trop Med Hyg. 2007 Apr;101(4):351-9
pubmed: 17028048
PLoS Med. 2008 Jun 17;5(6):e127
pubmed: 18563961
Am J Trop Med Hyg. 1992 Jul;47(1 Pt 2):2-7
pubmed: 1632473
Emerg Infect Dis. 2005 Jan;11(1):132-4
pubmed: 15705338
QJM. 1997 Dec;90(12):751-7
pubmed: 9536339
J Infect Dis. 2011 Nov 15;204(10):1613-9
pubmed: 21908728
Malar J. 2016 Nov 8;15(1):536
pubmed: 27821127
PLoS Med. 2019 May 29;16(5):e1002815
pubmed: 31167228
Lancet. 2005 Aug 27-Sep 2;366(9487):717-25
pubmed: 16125588

Auteurs

Dewi Patriani (D)

Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Kesehatan no.1, Sekip, Yogyakarta, 55284, Indonesia.

Eggi Arguni (E)

Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Kesehatan no.1, Sekip, Yogyakarta, 55284, Indonesia.

Enny Kenangalem (E)

Timika Malaria Research Programme, Papuan Health and Community Development Foundation, Jl. SP2-SP5, RSMM Area, Timika, Papua, 99910, Indonesia.
Mimika District Hospital, Jl. Yos Sudarso, Timika, Papua, 99910, Indonesia.

Saber Dini (S)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, 207 Bouverie Street, The University of Melbourne, Melbourne, Victoria, 3010, Australia.

Paulus Sugiarto (P)

Mitra Masyarakat Hospital, Jl. SP2-SP5-Charitas, Timika, 99910, Indonesia.

Afdhal Hasanuddin (A)

Mitra Masyarakat Hospital, Jl. SP2-SP5-Charitas, Timika, 99910, Indonesia.

Daniel Adrian Lampah (DA)

Timika Malaria Research Programme, Papuan Health and Community Development Foundation, Jl. SP2-SP5, RSMM Area, Timika, Papua, 99910, Indonesia.

Nicholas M Douglas (NM)

Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, PO Box 41096, Casuarina, Darwin, NT, 0811, Australia.

Nicholas M Anstey (NM)

Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, PO Box 41096, Casuarina, Darwin, NT, 0811, Australia.
Division of Medicine, Royal Darwin Hospital, Darwin, NT, 0810, Australia.

Julie Anne Simpson (JA)

Mitra Masyarakat Hospital, Jl. SP2-SP5-Charitas, Timika, 99910, Indonesia.

Ric N Price (RN)

Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, PO Box 41096, Casuarina, Darwin, NT, 0811, Australia.
Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, OX37LJ, Oxford, United Kingdom.
Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Jeanne Rini Poespoprodjo (JR)

Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Kesehatan no.1, Sekip, Yogyakarta, 55284, Indonesia. didot2266@yahoo.com.
Timika Malaria Research Programme, Papuan Health and Community Development Foundation, Jl. SP2-SP5, RSMM Area, Timika, Papua, 99910, Indonesia. didot2266@yahoo.com.
Mimika District Hospital, Jl. Yos Sudarso, Timika, Papua, 99910, Indonesia. didot2266@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH